Number of the records: 1
erytromycín
SYS d004917 LBL 00000nz--a2200000o--4500 005 20250606212902.6 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D02.540.576.500.992 066 $a 01 $c 03 150 $a erytromycín $x AA $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d000900 $Y Anti-Bacterial Agents $w P $a antibiotiká 550 $7 sllk_us_auth*d005765 $Y Gastrointestinal Agents $w P $a látky gastrointestinálne 550 $7 sllk_us_auth*d011500 $Y Protein Synthesis Inhibitors $w P $a inhibítory proteosyntézy 680 9-
$i A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. $2 eng 750 -2
$a Erythromycin $2 eng 980 $x M
Number of the records: 1